Search results
Results from the Tech24 Deals Content Network
Earnings per share were up 25% year over year to $0.35. However, there were some issues . DexCom's results weren't what the company -- or the market -- expected, for several reasons.
This month, three stellar dividend growth stocks caught my eye in the healthcare sector. Take a look at what makes them so special and why they are table-pounding buys this month. 1. Abbott Labs ...
List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...
Abbott Laboratories. Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Green Oaks, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and ...
The initial public offering was June 21, 2000 at US$6 per share. Cepheid stock was listed on the Nasdaq under the ticker symbol CPHD until it was acquired by Danaher in 2016. [35] [third-party source needed] The company's first CEO was Tom Gutshall, who held the position from 1996 to 2002. [36] In April 2002, John L. Bishop was appointed CEO. [2]
Abbott Laboratories said the market was overestimating the hit to sales of its glucose monitoring products from growing popularity of new diabetes drugs, adding the treatments could end up ...
Image Credits: Abbott. U.S. medical device maker Abbott is moving into making general-purpose consumer biosensing wearables. The company has been making continuous glucose monitor (CGM) hardware ...
For premium support please call: 800-290-4726 more ways to reach us